NEW YORK, Feb. 26 LAWFUEL – US Law Firm News, Law Jobs — Buchanan Ingersoll & Rooney PC announced today the addition of patent and intellectual property litigator
Constance S. Huttner, who will chair the firm’s Intellectual Property
Litigation Group. Prior to joining Buchanan, Huttner was a partner in the
Intellectual Property and Technology Group of Skadden, Arps, where she has focused on patent and technical litigation since establishing Skadden’s patent litigation practice in 1990. Huttner is a shareholder in Buchanan’s New York office.
The firm expects to add other patent litigation attorneys to Huttner’s practice in the coming weeks.
Huttner joins the 120 attorneys and patent agents who already practice in Buchanan’s IP and IP litigation groups. Intellectual Property has been a
major strategic focus of the firm for years, particularly since 2005 when
Buchanan merged with Burns Doane Swecker and Mathis, a top-ranked
intellectual property firm. Buchanan is currently ranked among the top 15
law firms in the nation based on annual volume of both the number of
patents filed and the number of U.S. trademark registrations issued.
“We’ve been looking to bring more patent litigators to Buchanan for
some time now, and we’ve found both talent and experience in Connie,” said Tom VanKirk, CEO of Buchanan. “Best of all, her practice ties in remarkably well with our firm. Connie’s work with pharmaceutical companies fits with our bio/pharma practice. Her experience with medical devices and cosmetics matches up with our health care and FDA practices. And her background providing patent opinions and advice in connection with mergers and acquisitions is in line with our corporate practice.”
VanKirk also indicated that Huttner’s practice fits into the firm’s
expanded strategic direction for the New York office. “We’re actively
recruiting real estate, corporate, litigation and intellectual property
attorneys in this market to further grow and develop some of our core
competencies,” he said.
Huttner has represented major companies such as Honeywell
International, Inc., Endo Pharmaceuticals, Inc., Valeant Pharmaceuticals
and United States Surgical Corporation. Recently, she represented Endo
Pharmaceuticals, Inc., in its successful Abbreviated New Drug Applications
(ANDAs) battle with Purdue Pharma L.P., involving OxyContin.
Huttner says she was drawn to Buchanan because of the firm’s in-depth
understanding of the unique aspects of an intellectual property practice,
and its strategic and economic commitment to the growth of its national
patent litigation practice.
“I see Buchanan as a firm with a strong commitment to the New York City market and to further developing practices that are already thriving. And, the firm has tremendous resources to apply to that end,” she said.
Huttner continued, “Joining Buchanan was an easy decision by every
measure. As a pure patent litigator, I add strength and experience to the
firm’s existing IP litigation practice, and I get the benefit and support
of a first-class team with a deep bench of technically trained lawyers.”
Ellen Shapiro, managing shareholder of the firm’s New York office,
described Huttner as a welcome addition to the firm. “Connie is very well-
regarded throughout the New York patent world – our office is lucky to have her, and, most importantly, our clients will benefit by having access to someone with her level of experience and talent.”
Constance S. Huttner is a shareholder in the New York office of
Buchanan Ingersoll & Rooney, and chairs the firm’s Intellectual Property
Litigation Group. She began her career at Skadden, Arps in 1980 litigating
hostile tender offers and other corporate control battles, and went on to
become one of the youngest – and one of the first women – to be named as a litigation partner at the firm. Connie founded Skadden’s patent litigation practice in 1990, and formally joined Skadden’s Intellectual Property and Technology Group in 1992.
Since 1990, Connie has focused her practice on patent and technical
litigation, as well as litigation involving trade secrets, advertising and licensing disputes. Connie has handled a variety of patent trials and
appeals involving Abbreviated New Drug Applications (ANDAs) and other
pharmaceutical issues, medical devices, software, cosmetics, electronic
instruments, coatings, blowing agents and mechanical devices. She also has handled false advertising, and trade secret matters involving English
muffins, chewing gum, detergents, food and sporting equipment.
Connie received her J.D. degree, magna cum laude, from Boston College,
where she was named to the Order of the Coif and the Boston College Law
Review. She earned her B.S. degree in cellular immunology from Ohio State
University, Phi Beta Kappa, at just 19 years of age.
About the Firm
Buchanan Ingersoll & Rooney PC (http://www.buchananingersoll.com) has more
than 550 attorneys and government relations professionals practicing
throughout the United States, with offices in New York, Philadelphia,
Newark, Pittsburgh, Washington, D.C., Alexandria, Harrisburg, Miami,
Princeton, San Diego, Silicon Valley, Tampa and Wilmington.
Effective July 1, 2006, Buchanan Ingersoll PC and Klett Rooney Lieber & Schorling PC merged to form Buchanan Ingersoll & Rooney PC. The merger made the combined firm one of the 80 largest in the country. Buchanan has undergone a series of acquisitions and additions during the past two years, including: a group of nine litigators from Saul Ewing; the 55 attorneys and patent professionals of Burns, Doane, Swecker & Mathis; a team of IP and
business litigators in San Diego; a group of three government relations
professionals in Washington, D.C.; a group of seven high-profile tax and
immigration lawyers in Miami; and a litigation boutique in New York.